Bronchodilator treatment and deaths from asthma: Case-control study

British Medical Journal

Volumn 330, Issue 7483, 2005, Pages 117-120

  Anderson, H Ross ^a,b   Ayres, Jon G ^a,b,c   Sturdy, Patricia M ^a   Bland, J Martin ^a,b   Butland, Barbara K ^a   Peckitt, Clare ^a   Taylor, Jennifer C ^a   Victor, Christina R ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Dept of Epidemiol and Pub Health ^*

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; METHYLXANTHINE; STEROID;

ADULT; ARTICLE; ASTHMA; AUTHORITY; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HUMAN; INHALATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIDE EFFECT; UNITED KINGDOM;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGE DISTRIBUTION; AGE OF ONSET; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; GREAT BRITAIN; HUMANS; INFANT; MIDDLE AGED; MUSCARINIC ANTAGONISTS; ODDS RATIO; REGRESSION ANALYSIS;

EID: 12344332812     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38316.729907.8F     Document Type: Article

References (14)

1. Dennis SM, Sharp SJ, Vickers MR, Frost CD, Crompton GK, Barnes PJ, et al. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Lancet 2000;355:1675-9.
2. Sturdy PM, Victor CR, Anderson HR, Bland JM, Butland BK, Harrison BD, et al. Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax 2002;57:1034-9.
3. Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.
4. Chung KF. The current debate concerning beta-agonists in asthma: a review. J R Soc Med 1993;86:96-100.
5. Beasley R, Pearce N, Crane J, Windom H, Burgess C. Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med 1991;21:753-63.
6. Blais L, Ernst P, Suissa S. Confounding by indication and channeling over time: the risks of beta 2-agonists. Am J Epidemiol 1996;144:1161-9.
7. Meier CR, Jick H. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK. Thorax 1997;52:612-7.
8. Williams C, Crossland L, Finnerty J, Crane J, Holgate S, Pearce N, et al. Case-control study of salmeterol and near-fatal attacks of asthma. Thorax 1998;53:7-13.
9. Spitzer WO, Suissa S, Ernst F, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
10. Lanes SF, Garcia Rodriguez LA, Huerta C. Respiratory meditations and risk of asthma death. Thorax 2002;57:683-6.
11. Guite HF, Dundas R, Burney PG. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax 1999;54:301-7.
12. Suissa S, Hemmelgarn B, Biais L, Ernst P. Bronchodilators and acute candiac death. Am J Respir Crit Care Med 1996;154:1598-602.
13. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
14. Graham V, Lasserson T, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev 2001;(2):CD 002741.